TSE Explores Drug Discovery – Identifying and Optimizing a Promising Drug
Published: May 28, 2020
Laura Elizabeth Lansdowne
In this episode we speak with Professor Paul Brennan from the University of Oxford about lead optimization, what to consider when designing a new drug, and much more.
Meet the Authors
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific editing, Laura worked at the Wellcome Sanger Institute and GW Pharma.
Custom Content Manager
Tiffany oversees the creation of custom content at Technology Networks and their sister publication, Analytical Cannabis. She holds a bachelor’s degree in neuroscience from the University of Leeds.